Pharmafile Logo
Pharmafocus logo
Advanced Search

After pressure from patients, ALS drug reviewed by FDA

March 25, 2022
Medical Communications

The FDA is meeting next week to review a drug closely watched for ALS, also known as Lou Gehrig’s disease, …

News

Angle PLC announces identifying therapeutic targets in TNBC patients

March 25, 2022
Medical Communications

A leading cancer research institute in Milan, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori, has published results of a study …

News

FDA grant Breakthrough Therapy Designation for RSV vaccine candidate in older adults

March 25, 2022
Medical Communications

Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate has received Breakthrough Therapy Designation from the FDA, for …

News

ViiV Healthcare announces label update for long-acting HIV treatment

March 25, 2022
Medical Communications

The FDA has approved a label update for Cabenuva (cabotegravir, rilpivirine), which makes the oral lead-in with cabotegravir and rilpivirine …

News

AstraZeneca cervical cancer treatment fails to meet endpoint in Phase III trial

March 24, 2022
Business Services

AstraZeneca has shared that results from its Calla Phase III trial of Imfinzi for the treatment of locally advanced cervical …

News

Spot the Difference: A Common Cold, or COVID-19?

March 24, 2022

Prior to the pandemic, if you got a runny nose and a sore throat, you would likely assume it was …

News

Novel therapy could revolutionise treatment for asthma, COPD, among others

March 24, 2022
Business Services

A multicenter research team in Texas has developed the first drug to treat the uncontrolled secretion of mucins in the …

News

FDA approval for castration-resistant prostate cancer

March 24, 2022
Business Services

The FDA has approved Novartis’ prostate cancer treatment, Pluvicto™, which is now expected to become available in a few weeks. …

News

Study finds COVID-19 may double severe complications in pregnancy

March 23, 2022
Research and Development

A Kaiser Permanente analysis of pregnant patients who tested positive for COVID-19 found more than double the risk of severe …

News

Alnylam sues Moderna and Pfizer over key vaccine ingredient

March 23, 2022
Research and Development

Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company, has sued Moderna and Pfizer over allegations that the firms used patented nanoparticle technology …

News

ONS says no evidence that COVID-19 vaccines lead to young deaths

March 23, 2022
Research and Development

The Office for National Statistics (ONS) has said that there is no evidence that COVID-19 vaccines have led to an …

News

Pfizer to supply UNICEF oral COVID-19 treatment for low- and middle-income countries

March 23, 2022
Research and Development

Pfizer have announced the signing of a supply agreement with the United Nations Children’s Fund (UNICEF), to deliver up to …

News

FDA approval for first drug for rare form of epilepsy

March 22, 2022
Manufacturing and Production

Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment …

News

MDMA improves PTSD symptoms, study finds

March 22, 2022
Manufacturing and Production

In findings presented at the American Chemical Society’s (ACS) Spring Meeting for 2022, researchers reported on follow-up results form a …

News

Pfizer recalls blood pressure drug due to potential carcinogen

March 22, 2022
Manufacturing and Production

Pfizer is voluntarily recalling certain hypertension medications due to the potential presence of impurities. The affected products have been distributed …

News
hand

Collaboration to offer heart rhythm checks to detect atrial fibrillation

March 22, 2022
Manufacturing and Production

Daiichi Sankyo and O’Brien’s Pharmacies Group have today announced the launch of a collaboration in North West England to offer …

News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …

Appointment

FDA approval for first in class immunotherapy for advanced melanoma

March 21, 2022
Sales and Marketing

The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, …

News

Spring COVID-19 booster launches for over-75s and high risk in England

March 21, 2022
Sales and Marketing

Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an …

News

UCLA’s HIV prevention and treatment centre receives $7.5 million NIH grant

March 21, 2022
Sales and Marketing

The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026